Pregnant Women Face Tough Choices About Medication. Medical Research Cuts Will Make It Worse

Pregnant women face tough choices about medication. Medical research cuts will make it worse

A panel convened in July 2025 by the Food and Drug Administration sparked controversy by casting doubt about the safety of commonly used antidepressants during pregnancy. But it also raised the broader issue of how little is known about the safety of many medications used in pregnancy, considering the implications for both mother and child—and how understudied this topic is.

Pregnant women face tough choices about medication use due to lack of safety data − here’s why medical research cuts will make it worse

More than 9 in 10 women take at least one medication during pregnancy, yet data on prescription drugs' effects on the fetus are sparse. Adam Hester/Tetra images via Getty ImagesA panel convened in July 2025 by the Food and Drug Administration sparked controversy by casting doubt about the safety of commonly used antidepressants during pregnancy. But it also raised the broader issue of how little is known about the safety of many medications used…

Pregnant women face tough choices about medication use due to lack of safety data − here’s why medical research cuts will make it worse - The Times Weekly

By Almut Winterstein, University of Florida and Sonja Rasmussen, Johns Hopkins University More than 9 in 10 women take at least one medication during pregnancy, yet data on prescription drugs’ effects on the fetus are sparse. Adam Hester/Tetra images via Getty Images A panel convened in July 2025 by the Food and Drug Administration sparked controversy by casting doubt about the safety of commonly used antidepressants during pregnancy. But it als…